Bortezomib
- Product NDC
- 63323-721
- 11-digit product format
- 633230721
- Labeler code
- 63323
- Product ID
- 63323-721_81e8728c-5928-4029-8aa0-0e7f761af75a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bortezomib
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Fresenius Kabi USA, LLC
- Application
- NDA205004
- Marketing category
- NDA
- Marketing start
- 2017-11-06
- Marketing end
- 0000-00-00
- Substance
- BORTEZOMIB
- Active strength
- 1 mg/mL
- Pharmacologic classes
- Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63323-721-10 | 63323072110 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-721-10) > 10 mL in 1 VIAL, SINGLE-DOSE | 2017-11-06 | 0000-00-00 | No | No | Current |